Nanopublications

Matches in Nanopublications for { ?s ?p "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

Showing items 1 to 11 of 11 with 100 items per page.

NP383669.RA8KBDhmu_qKYaYtZaNL-ftMWLdvOUqQ7VvYPELf6LCRM130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383669.RA8KBDhmu_qKYaYtZaNL-ftMWLdvOUqQ7VvYPELf6LCRM130_provenance.
NP581088.RA3yyhUQ0Y-HBagYKBGnCUlGZnT-pEzaTyLqQUKTyc8CQ130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581088.RA3yyhUQ0Y-HBagYKBGnCUlGZnT-pEzaTyLqQUKTyc8CQ130_provenance.
NP260201.RA8sC8wMJh_X0XttZyOwvrR9nCy3x8hF-evC2cOlrIlhw130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260201.RA8sC8wMJh_X0XttZyOwvrR9nCy3x8hF-evC2cOlrIlhw130_provenance.
assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP783532.RA4tk4tot5lp4zWC0pkEPZu2F4Q-yw2dOm1s9JAB-y6EQ130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783532.RA4tk4tot5lp4zWC0pkEPZu2F4Q-yw2dOm1s9JAB-y6EQ130_provenance.
NP783533.RAy-brNt5RZUX2uAikTyIDKDxdXenwn3bYcjKTIFloUwE130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783533.RAy-brNt5RZUX2uAikTyIDKDxdXenwn3bYcjKTIFloUwE130_provenance.
NP379929.RApq-T3qU2IkHbDnCgtrYyy61yzjmJ7zvqHd5nX2zlVwY130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379929.RApq-T3qU2IkHbDnCgtrYyy61yzjmJ7zvqHd5nX2zlVwY130_provenance.
NP783529.RAlt6cwbNKTZE3i1AkpdXXq0Uly5JMWXy3IRztxe4N7e0130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783529.RAlt6cwbNKTZE3i1AkpdXXq0Uly5JMWXy3IRztxe4N7e0130_provenance.
NP783531.RAsYPrGSuAuUV_zZnd7COtsr6G6NKV3F0e3CYvA0Yhqgs130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783531.RAsYPrGSuAuUV_zZnd7COtsr6G6NKV3F0e3CYvA0Yhqgs130_provenance.
NP783530.RAE_RNWffODmlyEk3th21JINIHwHvQXmst52td0Ojpfbs130_assertion description "[Amplification rates of pure DCIS and DCIS associated with invasive cancer did not differ significantly (pure DCIS vs. DCIS associated with invasive cancer: HER2 22.7 vs. 24.2%, ESR1 19.0 vs. 24.1%, CCND1 10.0 vs. 14.8%, MYC 11.8 vs. 6.5%; P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783530.RAE_RNWffODmlyEk3th21JINIHwHvQXmst52td0Ojpfbs130_provenance.